Voyager Therapeutics stock soars on Pfizer deal
October 06, 2021 at 11:24 AM EDT
Shares of Cambridge biotech Voyager Therapeutics Inc. are up more than 60% on the news that the company inked a $630 million licensing deal with Pfizer Inc.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |